Kaylan Pustover
Dermatology · New York, NYNPI 1871901918
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 468 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations.
Across 468 payments — averaging $18.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Galderma Laboratories, L.p.$1K
- Johnson & Johnson$1K
- Incyte Corporation$774
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$601
- Mayne Pharma Commercial LLC$499
- plus $3K from 27 others
What the payments were for
- Food & beverage$8,24597%
- Education$2903%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 63 | $1,242 |
| Galderma Laboratories, L.p. | 54 | $1,158 |
| Johnson & Johnson | 69 | $1,014 |
| Incyte Corporation | 66 | $774 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 37 | $601 |
| Mayne Pharma Commercial LLC | 36 | $499 |
| Novartis | 22 | $493 |
| Regeneron Healthcare Solutions, Inc. | 18 | $424 |
| Sanofi | 13 | $339 |
| Lilly USA, LLC | 10 | $203 |
| Sun Pharmaceutical Industries Inc. | 10 | $200 |
| Pfizer | 9 | $186 |
| EPI Health, LLC | 7 | $172 |
| VYNE Pharmaceuticals Inc. | 7 | $136 |
| LEO Pharma Inc. | 6 | $136 |
| Dermavant Sciences, Inc. | 5 | $132 |
| Amgen | 6 | $105 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Botanix SB Inc | 3 | $82 |
| Almirall LLC | 4 | $78 |
| UCB, Inc. | 3 | $75 |
| Dermira, Inc. | 3 | $57 |
| Journey Medical Corporation | 2 | $54 |
| Arcutis Biotherapeutics, Inc. | 2 | $52 |
| Bristol Myers Squibb | 2 | $41 |
| Medimetriks Pharmaceuticals, Inc. | 2 | $33 |
| Verrica Pharmaceuticals Inc. | 1 | $32 |
| Encore Dermatology Inc. | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| Acelrx Pharmaceuticals, Inc. | 1 | $23 |
| Aclaris Therapeutics, Inc. | 1 | $20 |
| Mission Pharmacal Company | 1 | $14 |
| Prugen, Inc. Pharmaceuticals | 2 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AKLIEF$245
- ORACEA$230
- EPIDUO FORTE$106
- SOOLANTRA$106
How this compares
$8,535 in reported general payments places this provider in the 70th percentile of 1,151 dermatology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Minoxidil | 13 | $153 |
Paid to pharmacies, not to this prescriber.
Other dermatology in New York
- Alexandra GolantNew York$3.6M
- David CohenNew York$3M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Joshua ZeichnerNew York$2.1M
- Emma GuttmanNew York$1.7M
- George HanNew York$1.6M
- Amy SpizuocoNew York$1.3M
- Andrew AlexisNew York$834K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.